(NYSEA: IBIO), an AI-driven innovator of precision antibody immunotherapies, in collaboration with AstralBio Inc., announced today the development of an antibody that inhibits the function of Activin ...

By adapting artificial intelligence models known as large language models, researchers have made great progress in their ...

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Boehringer Ingelheim BioXcellence™ and Inc. today announced that they successfully applied Sutro’s proprietary cell-free expression technology on a commercial scale to manufacture luveltamab ...

NIH researchers discover novel class of antibodies that could lead to next generation of interventions against malaria.

Novel antibodies have the potential to pave the way for the next generation of malaria interventions. Researchers at the ...

Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria.

A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a study from researchers at the National Institutes ...

“Maybe generative AI isn't just going to create beautiful cartoons and limericks to entertain ourselves and one another, and ...

By Dr. Chinta Sidharthan A novel computational framework revolutionizes antibody design, offering precise predictions and ...

Star Therapeutics, a clinical stage biotechnology company discovering and developing best-in-class antibodies, today ...